Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticoids in Severe Community-acquired Pneumonia
NCT00908713Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jan 2004
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in community acquired pneumonia (CAP) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Rate of non-response to empiric antimicrobial treatment at 5 days. Started Jan 2004; status: completed.
02
Drugs
methylprednisolone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00908713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908713.